For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Documents
Separation of Solifenacin Succinate Stereoisomers per USP Monograph using Lux 5 µm Amylose-1 Column
In this application, the stereoisomeric separation between Solifenacin Succinate and its stereoisomers occurs using the Lux Amylose-1 chiral column according to the USP monograph for Solifenacin Succinate.
Separation of Solifenacin Succinate Stereoisomers per USP Monograph using Lux 5 µm Amylose-1 Column
In this application, the stereoisomeric separation between Solifenacin Succinate and its stereoisomers occurs using the Lux Amylose-1 chiral column according to the USP monograph for Solifenacin Succinate.
Document Type:
Technical Notes
Target Industries:
Pharmaceutical
Techniques:
HPLC, HPLC-Chiral
Brands:
Lux
Separation Modes:
Chiral
Phases:
Lux Amylose-1
save_alt Download
favorite_border
Phenomenex logo
Headquarters
411 Madrid Avenue, Torrance, CA 90501
t: (310) 212-0555 f: (310) 328-7768

OUR PRODUCTS AND SERVICES

Products

Techniques

Industries

OUR COMPANY 

About Phenomenex

Our Humanity

Our People

Blog

Danaher Life Sciences

Stay up to date on the latest from Phenomenex
Iso logo
Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Cookie Settings © 2023 Phenomenex Inc. All rights reserved.